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ABSTRACT 
Carter, Carlos, Devon M.S., Purdue University, December 2016. Antibacterial Activity of 
Essential Oil Encapsulated Sodium Iota-Carrageenan Fibers. Major Professors: Dr. Arun 
K. Bhunia & Dr. Srinivas Janaswamy 
 
Spoilage microorganisms cause food waste and loss of quality. While the 
foodborne pathogen outbreaks lead to thousands of hospitalizations and deaths. 
Essential oils (EOs), plant extracts, possess the required antimicrobial activities and thus 
their usage stands out as a feasible approach for controlling the undesirable bacterial 
growth in food systems. However, EOs are highly volatile and lose their activity upon 
exposure to environmental conditions. In this regard, their encapsulation in Generally 
Recognized As Safe (GRAS) matrices such as food grade polysaccharides especially iota-
carrageenan could be one of the viable alternatives. Iota-carrageenan, sulfated 
polysaccharide from marine algae, is being used in food, pharmaceutical and medical 
application as a gelling and thickening agent. Ordered networks composed of water 
pockets of the dimensions of EOs could be created by stretching the oriented fibers of 
iota-carrageenan. These water pockets readily encapsulate the EOs, protect from 
external stresses, e.g. heat, light, moisture, and release in a controlled manner. Herein, 
two EOs, carvacrol and eugenol mixed in ethanol and Tween 80 were encapsulated in 
sodium salt form of iota-carrageenan fibers. The antimicrobial activity was tested
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against Listeria innocua F4248, Listeria monocytogenes F4244, Salmonella Enteritidis 
ENT 1344, Salmonella enterica serovar Heidelberg 513, Escherichia coli O157: H7 ATCC 
43295, and Staphylococcus aureus ATCC 25923 using the disc diffusion and macro broth 
dilution assay. Results reveal that the complexes dissolve in the deionized water and EO 
release in about 40 mins. The complexing, indeed, have inhibitory effect on the growth 
of the microorganisms, especially in significantly reducing the proliferation of L. 
monocytogenes and L. innocua. Overall, the intrinsic functionality of essential oils could 
be preserved by encapsulating them in the ordered polysaccharide matrices for 




    
 
CHAPTER 1. REVIEW OF ESSENTIAL OILS: COMPOSITION, CURRENT APPLICATIONS, 
AND POTENTIAL DELIVERY SYSTEMS FOR FOOD  
1.1 Introduction 
Foodborne illnesses are major issues in the world today. In year 2013, the Center for 
Disease Control (CDC) reported 19,162 laboratory-confirmed cases of infection, 4,276 
hospitalizations and 88 deaths [FoodNet, 2016].  The CDC also estimates every 1 in 6 
Americans are infected with a foodborne illness. The top contributing pathogens are 
Salmonella, Listeria monocytogenes, Campylobacter spp., Toxoplasma gondii, and the 
Norovirus. Food is generally contaminated during processing and handling - person with 
poor hygiene - cross contamination and poor sanitation in facilities. Bacterial 
persistence and resistance has also been a growing challenge in the agricultural and 
food industry. Fortunately, the government, food industry, and universities have made 
great strides in reducing foodborne illness outbreaks through research. 
In 2011, the Food Safety Modernization Act (FSMA) was signed and it shifted the 
focus from responding to contamination to preventing it. The FSMA further strengthens 
the food system by allowing the FDA to mandate new legislation on contamination 
prevention, inspection & compliance, response, imported products, and enhanced 
partnerships with state and local agencies (U.S. Food and Drug Admin). 
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According to the CDC, in 2012, laboratory-confirmed infections for Listeria, 
Shigella, Shiga toxin-producing E. coli O157:H7, and Yersinia decreased by about 6, 13, 
10, and 6%, respectively. However, confirmed infections for Campylobacter, Salmonella, 
and Virbrio increased by about 14, 3, and 43%, respectively. Microbial contamination 
and spoilage continue to be issues to be addressed in the agricultural and food sectors 
around the world. Thus, there is further scope for improving the current traits so as to 
decrease the food borne illness outbreaks.  
Many research groups have explored the option of incorporating the 
antimicrobial compounds (AMCs) into food matrix towards limiting the pathogenic 
growth. Among the several available AMCs, essential oils (EOs) have found an 
indispensable niche in the food safety and preservation. EOs are aromatic liquids 
obtained from plants. They can be obtained by expression, fermentation, or steam 
distillation (Burt, 2004). EOs have been recognized for their antimicrobial activity for 
centuries. They were primarily used for medicinal and pharmaceutical purposes. 
However, stability has been an issue in introducing EOs in food systems as they are 
highly volatile and can be easily oxidized by light. Additionally, high levels of fat and/or 
protein in food could shield bacteria from the action of EOs or interact with them and 
reduce the antimicrobial effect. Consequently, increased amounts of EOs have to be 
used to achieve the same antimicrobial activity effect. However, the organoleptic 
impact of pungent EOs should be considered, as they tend to alter the taste and smell or 
as well exceed the acceptable flavor thresholds. In this regard, various encapsulation 
methods have been employed to alleviate the challenges of EOs addition to food 
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systems. Rest of the section will focus on the functional components, current 
applications and delivery systems of EOs  
1.2 History of Essential Oils (EOs)  
The production of oils from distilled plant material dates all the way back to 
more than 2,000 years. Greek historian, Herodotus (484-425 B.C.), Roman historian Pliny 
(23-79) and Dioscorides mention oil of turpentine in their literature, but with limited 
information on how it was produced. During the Middle Ages, rose oil was regarded as 
an undesirable byproduct from producing distilled rose water. Odoriferous oils and 
ointments were traded in ancient Greece and Rome; however, they were not real EOs. 
The oils traded were produced by placing flowers, roots and other plant material into a 
fatty oil of high quality, exposing the glass bottles to the sun and then separating the oil 
from the solid constituents (Guenther, 1948). The first description of real EOs from 
distillation has generally been attributed to Catalan physician, Arnald de Villanova who 
may have also introduced distillation into European therapy. It should be noted the 
term “distilled” does not have the same meaning now as it did in ancient and medieval 
writings, and it is possible that modern distilled EOs might possess different contents 
than the ancient ones. 
Significant development of oils began in the thirteenth century, when 
pharmacies started to prepare “remedy oils’ and studied the properties and 
physiological effects (Surburg, 2006). The actual use of essential oils does not become 
common until and after the scientific discoveries made during the 21st century. 
Hieronymus Brunshwig’s mentions oils of turpentine, juniper wood and rosemary in his 
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book “Liber De Arte” (Guenther, 1948). Loncier addresses the medicinal value of EOs 
and further expresses that distillation is rather a recent invention but not as an ancient 
invention (Guenther, 1948). The definition of distillation indeed changed over time and 
scientific advancement. German physician Valerius Cordus brought more knowledge on 
the nature and preparation of essential oils in the “De Artificiosis Extractionibus” 
(Guenther, 1948). Neapolitan, Giovanni Battista della Porta also wrote a very important 
publication on essential oils, ‘De Destillatione libri IX,”. Porta differentiates between 
fatty and distilled oils, their preparation, the ways of separating the volatile oils 
(Guenther, 1948).  
 The systematic study of EOs began towards the end of the 18th century. 
Lavoisier and Houton de la Billarddiè analyzed oil of turpentine and found that the ratio 
of carbon to hydrogen to be five to eight and the same ratio was also found in all 
hermiterpenes, terpenes, sequiterpenes and polyterpenes (Guenther, 1948). French 
Chemist Dumas also analyzed various stearoptenes (Guenther, 1948). Berthelot focused 
on the hydrocarbons in EOs (Guenther, 1948). Further advancement led to more 
discoveries and production of newly identified constituents. Some researchers refer to 
this period of advancement as the “Elizabethan Age” of EOs. The industrialization of EOs 
was indeed an important step in the history of natural fragrance materials.  
The first EO produced on a large scale in the US was oil of turpentine. This was 
due to many southern states being covered with pine forest like North and South 
Carolina and Georgia as well as the national and global demand for EOs (Guenther, 
1948). Additionally, oils from three American plants of sassafras, wormseed and 
5 
 
    
wintergreen were also produced in large scale. Oils of wintergreen and wormseed were 
highly used in North America. Williams Proctor, Jr. also known as “The Father of 
American Pharmacy” identified the main components of the oils of wintergreen 
(Guenther, 1948). The wintergreen oils gained medical, cosmetic and flavor applications. 
There is no evidence of large-scale production of wintergreen oil before the nineteenth 
century apart from the US (Guenther, 1948). James Thatcher noted in 1821 that oil from 
wormseed is one of the most efficacious vermifuge medicines ever employed 
(Guenther, 1948). Additionally, the oil of peppermint was also produced in bulk in North 
America. It is believed that the American distillation of peppermint oil on a commercial 
scale had its origin in New York during 1816 (Guenther, 1948). In 1850, single organic 
compounds were employed as fragrance materials. This resulted from the isolation of 
cinnamaldehyde from cinnamon oil (Dumas and Pèligot, 1834) and benzaldehyde from 
almond oil (Surburg and Panten, 2006). Certainly, the vast production of EOs took place 
during the twentieth century.  
1.3 Current applications of EOs 
EOs have been employed for various applications in food, pharmaceutical and 
perfumes. Single components of EOs have been isolated and used in flavoring or 
perfumery. Geraniol is isolated from cintronella oils and in small quantities to emphasize 
citrus notes. Menthol is isolated from cornmint oil and is used for its refreshing effect in 
cigarettes, toothpastes, chewing gum, snacks, and medicine (Surburg and Panten, 2006). 
EOs are also popular in the aromatherapy market holding over 2% of the total market. 
EOs and their components, either plant extracts or synthetically produced, have also 
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been used as food flavorings (Burt, 2004). Their antimicrobial properties and 
components have been adopted for various applications.  
Many EOs are used as flavoring agents in food categories like meat, alcoholic 
beverages, soft drinks and savory foods. The pharmaceutical industry added EOs and 
their derivatives in cough medicines to mask undesirable odors and flavors. EOs have 
also been used in pharmaceutical preparations of ointments and lotions for 
dermatological disease and skin healing effects. EOs of elemi have been used as a 
diagnostic reagent in blood test.  Interestingly, oils of calamintha have been used to lure 
wild cats (Surburg and Panten, 2006). In the veterinary field, EOs have been used as 
preventatives of ticks and fleas. Additionally, they have been employed as a 
prophylactic, in incipient paralysis, for rheumatism and arthritis and to get rid of lice. 
Domca, in Alhendin, Granada, Spain produces DMC Base, which comprises of 50% EOs 
like rosemary, sage and citrus. Bavaria Corp. in Apopka, FL produces Protecta One and 
Proteca Two which are blended herb extracts and are Generally Recognized As Safe 
(GRAS) as food additives in the US (Burt, 2004).  
1.4 Composition of EOs 
EOs are synthesized by all the plant organs (flowers, buds, seeds, leaves, twigs, 
bark, herbs, wood, fruits and roots) and are stored in secretory cells, cavities, canals, or 
glandular trichomes. The proportions of the components present vary greatly. Factors, 
like the plant type, geographic conditions, climate, harvest period and processing 
technique could have an effect on the chemical composition. In general, they have a 
complex composition and contain several hundred different components. The majority 
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includes terpenes, monoterpenes, and sequiterpenes. Additionally, allyl- and 
propenylphenols are also important components. Their antioxidant activity correlates 
well with the content of oxygenated phenolic monoterpenes (Bozin et al., 2006). The 
individual contents play specific roles in the properties such as antimicrobial, 
antioxidant, and anti-inflammatory. Although numerous EOs have been chemically 
characterized, as of today, the composition-functionality relationship is not well 
understood yet.  
1.4.1 Antibacterial Components 
The antibacterial activity of many EOs or EO components has already been 
demonstrated by many research groups. There is some evidence that minor 
components play a vital role in the antimicrobial activity, producing a synergistic effect 
with major components. It has been reported that the phenolic components of essential 
oils are responsible for the antibacterial properties (Burt, 2004). In general, 
antimicrobial activity can be attributed to more than one component of an essential oil. 
For example, oil from Thymus vulgaris (Thyme) contains thymol, carvacrol, γ-Terpiene, 
and p-Cymeme, and all have been proven to be antibacterial. Origanum vulgare 
(oregano) also contains these same components in different amounts. Rosmarinus 
officinalis (rosemary) also contains four antimicrobial compounds, α-pinene, Bornyl 
acetate, Camphor, and 1,8-cineole (Burt 2004).  
The EOs and EO components are lethal to bacteria at various concentrations. 
Baydar et al., 2004 showed oil from oregano and black thyme created larger zones of 
inhibition than wild oregano at various concentrations. These oils contained high 
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amounts of carvacrol. Oils from medicinal plants from the Democratic Republic of Congo 
were screened against several bacterial species. The most antibacterial EOs were those 
isolated from Eucalyptus camadulensis and Eucalyptus terticoris (12-30 mm zone of 
inhibition diameter) (Cimanga, 2010).  Other EOs show exceptional antibacterial activity 
as well (≤ 15mm zone of inhibition diameter). Eucalyptus propinqua, Eucalyptus 
urophylla and Ocimum gratissimum oils weren’t as effective as others in this study. They 
reported that no correlation was observed between the amount of major constituents 
such as 1,8-cineol, α-pinene, p-cymeme, cryptone, or thymol and the antibacterial 
activity (Cimanga, 2010).  
Three EOs obtained from different species of Thymus plants growing wild in 
Sardinia was analyzed by GC/MS and their antimicrobial activity was determined against 
multiple strains of bacteria (Cosentino, 1999). The results showed the species had 
comparable antimicrobial activity to the commercial reference, Thymus capitatus. The 
major components of the oils were α-pinene, thymol, and carvacrol. Interestingly, the 
reference EO contained higher amounts of α-pinene (25.2%) than the wild EOs (0.8-
1.9%) (Cosentino, 1999).  
Eleven EOs (Cananga odorta, Cupressus sempervirens, Curuma longa, 
Cymbopogon citratus,  Eculyptus globulus, Pinus radiate, Piper crassinervium, Psidium 
quayava, Rosmarinus officinalis, Thymus citriodorus, Zinger officinale)  were screened to 
test for antioxidant, antiradical, and antimicrobial activity.  The minimum inhibitory 
concentration of the oils was determined by the antimicrobial disc diffusion assay 
against 5-food spoilage yeast. Most EOs tested showed moderate antimicrobial activity 
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against the yeast. Piper crassinervium, which was never analyzed before, contained high 
amounts of limonene (26.6%), α- and β-pinene (10.0% and 15.2%, respectively). There 
weren’t many differences observed in composition by C. citratus, C. sempervirens, E. 
globulus, C. odorata. The composition of other oils was unique (Sacchetti, 2005).  
In a study, sodium nitrate was used to induce the inhibition of Lactobacillus 
growth by monolaurin and eugenol. Combinations of 100 to 250 ppm monolaurin with 
500 and 100 ppm eugenol, and 0.2% were more effective at preventing detectable 
growth of 5 meat spoilage and 2 pathogenic organisms (Blaszyk, 1998). Microemulsions 
composed of eugenol, poly (vinyl alcohol), and Surfynol ® 465, were electrospun to 
create nanofiber carrier systems. The eugenol nanofibers were successful at suppressing 
the growth of Salmonella enterica serovar Typhimurium (2476 and 2576) and Listeria 
monocytogenes (Scott A and 101) (Kriegel, 2010). 
EOs from lemon, sweet orange and bergamot and their components, linalool and 
citral had antibacterial effects as direct oil and vapor form against Campylobacter jejuni, 
E. coli O157, L. monocytogenes, Bacillus cereus and S. aureus. Only linalool, bergamot, 
and citral had MICs acceptable for food application (0.06-0.125% v/v, 1-0.125% v/v, and 
0.03-0.06% v/v, respectively) (Fisher and Philips,2006).  
1.4.2 Antioxidant Components 
The antioxidant activity of EOs has been examined by many using various 
methods. Yang et al. (2010) found that Lanvandula angustifolia Mill oil from Australia 
was effective against lipid peroxidation (Yang, 2010.) The main contents of this oil are 
linalool and lynalyl acetate. Wei and Shibamoto (2010) evaluated the antioxidant 
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activity of oils from thyme, cloves, and basil using the conjugated diene assay. All oils 
had comparable antioxidant activity levels comparable to α-tocopherol, a common 
antioxidant. By conducting the β-carotene test, Joshi et al. (2010) showed that oils of 
Dodecadenia grandiflora, Lindera pulcherrima, and Persea gamblei were able to inhibit 
the oxidizing activity of the radical linoleic acid peroxide. Sesquiterpenoids were the 
major contents in this oil. Furanodienone and germacrene D were main components of 
Dodecadenia grandiflora, while furanodiene and curzerenone were the main 
components of Lindera pulcherrima oil. Oils from Persea gamblei were constituted by β-
caryophyllene, γ-gurjunene and β-cubenee.  Mighri et al. (2010) studied the oils of 
Artemisa herbalba also using the bleaching test. The results suggest four oil types β-
thujone, α-thujone, thujones (α + β), and 1,8 cineole/ camphor/ thujones (α + β) that 
exhibited weak antioxidant activity that was attributed to the absence of nonphenolic 
compounds.  
Using thiobarbituric acid reactive substances, Patil et al, (2010) showed oils from 
Ageratum conyzoides prevented lipid peroxidation better than the reference Butylated 
hydroxyanisole (BHA) (Patil, 2010). These oils were dominated by precocene I and 
precocene II. The antioxidant activity of five spice plants in the Mediterranean diet was 
also studied using the TBARS test (Viuda-Martos, 2010). All essential oils tested (Thymus 
vulgaris., [Eugenia caryophyllus (C. Spreng) Bell et Hare], Origanum vulgare L., Salvia 
officinalis L. and Rosmarinus officinalis L.) had antioxidant activity, but Thymus vulgaris 
was the most comparable to the reference chemical, butylated hydroxytoluene. The 
spices were predominated by Terpinen-4-ol, γ-terpinene, cis-sabinene hydrate, linalool 
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and p-cymeme. Oils from Capparis spinosa L. and Crithmum maritimum were evaluated 
by the TBARS method. They found that at the highest concentration, the oils showed 
lower ability to inhibit lipid peroxidation than butylated hydroxyanisole, but close to 
that of butylated hydroxytoluene. The differences among the antioxidant activity were 
not significant as compared to the chemical compositions.  The major component in 
Capparis spinose oil was methyl isothicynate, while Crithmum maritimum oil was 
dominated by sabiene and limonene (Kulisic-Bilusic, 2010). On contrary, Miguel et al. 
(2010) showed oils from various aerial parts and seeds from Foeniculum vulgare Mill 
were pro-oxidant at higher concentrations (750 mg/ml for the areal parts and 1,000 
mg/L for seeds). Aerial parts of the plant were dominated by trans-anethole and seeds 
by methyl chavicol.  
The aldehyde/carboxylic acid assay is convenient for evaluating the effects of 
antioxidants against slow oxidation that occur over longer periods of time in foods 
(Miguel, 2010). Using this method, Thymus vulgaris, Eugenia caryophyllus, 
Cinnamomum zeylanicum Blume. Ocimum basilicum L and Illicum verum Hook f. 
prevented oxidation of hexanal to hexanoic acid after 40 days of storage. Interestingly, 
the results showed the low importance of phenolic compounds to prevent hexanal 
oxidation, as Illicium verum oil was primarily dominated by anethole (Wei and 
Shibamoto, 2010).  
The formic acid measurement method is an automated test that measures the 
conductivity of low molecular weight fatty acids (formic acid) produced during oxidation 
of lipids (Miguel, 2010). The antioxidant activity of five spice plants found in the 
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Mediterranean diet was evaluated by the formic acid measurement. The results showed 
the oils of Thymus vulgaris and Origanum vulagre L.  showed the best antioxidant 
activity, but less than the reference, BHT.  Carvacrol was the main component of 
Origanum vulagare L. showed the greatest antioxidant activity (Viuda-Martos, 2010).  
1.4.3 Anti-inflammatory Components 
EOs are known to possess anti-inflammatory properties. Archidonis acid is 
released from cell membranes in inflammatory response. It is metabolized by 
Lipoxygenase pathways (Miguel, 2010). Essential oils from Citrus aurantiuum subsp. 
bergamia, Cinnamomun zeylanicum Blume, Eucalyptus globus Labill, Juniperus 
communis L. and Thymus vulgaris L., showed strong lipoxygenase inhibitory effects. 
These oils were dominated by limonene, linalyl acetate, β-trans-caryophyllene, 1, 8-
cineole, p-cymeme, thymol and eugenol. The authors attributed the anti-inflammatory 
activity to 1, 8-cineole, β-trans-caryophyllene, and α-pinene. Chamazulene and α-
bisabolol were major components of oils from the four plants of the Helichrysum species 
in South Africa in the inhibition of 5-lipoxygenase. Those same components were also 
present in chamomile essential oil. EOs of Alpinia murdocii Ridl., Alpinia scarbra, and 
Alpinia pahangeneis Ridl have also been shown to be good 5-lipoxygease inhibitors. Oils 
from the leaves were dominated by β-Pinene, α-pinene and sabiene, while the rhizome 
oils were dominated by γ-selinene, α-selinene and α-panasinsen (Kamatou, 2006).  
Anti-inflammatory agents can inhibit the secretion of pro-inflammatory 
cytokines (Miguel, 2010). Interlukin-1β (IL-1β) and tumor necrosis factor-α (TNF- α) are 
cytokines that play major role in inflammatory response. Monocytes/ macrophages are 
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the major sources of TNF- α in inflammatory responses. IL-1β can be produced by a 
various cell lines like monocytes, macrophages, fibroblasts, and endothelial cells. 
Researchers found that oil from Melaleuca alternifolia Cheel was able to 
suppress the production of TNF-α and IL-1β in vitro. The oil was predominated by 
terpinen-4-ol (Hart, 2006). EO of Cheistocalx operculatus inhibited lipopolysaccharide 
(LPS)-induced secretion of TNF- α and IL-1β (Dung, 2006). The same species reportedly 
also suppressed pro-inflammatory cytokine and stimulated the secretion of the anti-
inflammatory IL-4 and IL-10. EO from Taxandrua fragans decreased the production of 
TNF-α and IL-6. It was mainly composed of 1,8-cineole and α-linalool (Hammer, 2008).  
EO extracted from the leaves of Cinnamomum osmophleom had the ability to 
inhibit the production of IL-1β and IL-6 but not TNF- α. This was attributed to the 
content of 1,8-cineole, santoline, spathulenol and caryophyllene oxide. The anti-
inflammatory activity of this species could also be due to cinnamaldehyde (Chao, 2005). 
Cinnamaldehyde isolated from leaves of Cinnamomum osmophloeum inhibited the 
secretion of IL-1β and TNF- α in multiple cell lines (Chao, 2005). Interestingly, oil from 
Cordia verbenacea reduced TNF- α levels, but not IL-1β (Passos, 2007). Other 
researchers showed that α-humelene isolated from the same species significantly 
reduced TNF- α and IL-1β levels in the tissue of the rat paw (Medeiros, 2007). Some 
single components of EOs could be more effective for specific functions (antimicrobial, 
antioxidant, anti-inflammatory).  
Using an immunoassay, some researchers reported that EO from Cryptomeria 
japonica inhibited IL-1β, TNF- α, and IL-6 remarkably. This oil mainly contained kaurene, 
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elemol, γ-eudesmol and sabiene (Yoon, 2009). These same cytokines were also inhibited 
by oil from Artemisia fukdo, mainly dominated by α-Thujone, β-thujone, camphor and 
caryophyllene (Yoon, 2010). Main constituents of Cymbopogon citratus oil, geranial and 
neral, inhibited the secretion of IL-1β and IL-6 (Sforin, 2009). They later reported 
eugenol isolated from Syzgium aromaticum inhibited the release of PGE2, TNF-α, and IL-
1β (Rodrigues, 2009). Lin et al. reported, citral, the main component in oil from 
Cinnamomum isularimontanum Hayata, inhibits TNF-α. IL-1 and TNF-α levels were 
reduced in mice treated with oil from Pterodon emarginatus. The main components 
were germacrene D, β-elemene and caryophyllen. Combinations of thyme and oregano 
oils were capable of reducing levels of IL-1β and IL-6 (Dutra, 2009).  
1.5 Encapsulation and Carrier Systems for EOs 
As stated previously, incorporation of EOs and EO components has been a 
challenge for the food industry. High concentrations of EOs have to be used in food to 
retain their functional properties.  EOs are very pungent and could change the 
organoleptic properties of foods. Additionally, food ingredients can protect the 
pathogenic and food spoilage microorganisms from the action of EOs (Gutierrez, 2008). 
Consequently, encapsulation and delivery systems for EOs has intrigued the interest of 
many researchers.  Encapsulation, microemulsions, electrospraying, and electrospinning 
has been used to advance the application of EO and EO components in food. These 
methods could be useful in incorporating EOs in food to extend the shelf life and making 




    
1.5.1 Encapsulation of EOs 
Oils isolated from oregano red thyme, and cassio have been encapsulated into 
zein nanospheres. Scanning Electron Microscopy (SEM) images indicated that the 
powders were made up of irregularly shaped particles, approximately (50 µm) 
containing closed-packed nanospheres (Parris, 2005). Oils extracted from eucalyptus 
and lemon peel were encapsulated as a mean to control their release. The SiO2 were 
prepared by employing a sol-gel method to oil-in-water-in-oil multiple emulsions. The 
release profiles indicated depended on the chemical properties of each component 
(Sousa, 2014).  
Essential oils distilled from Artemisia afra, Eucalyptus globulus and Melaleuca 
alternifolia were encapsulated into diasteroyl phosphatidycholine and 
phosphatidylethanolamine liposomes employing a reverse phase evaporation 
technique. The MIC assay results showed that E. globulus and M. alternifolia 
encapsulated liposomes were able to inhibit the microbial growth comparable to non-
encapsulated oils. The addition of the chitosan coating did enhance the antimicrobial 
activity of the liposomes and had positive effect on the membrane stability (van Vuuren, 
2010). Thyme essential oils were encapsulated into chitosan-benzoic acid nanogel (CS-
BA) to enhance the antimicrobial activity against Aspergillus flavus. Under sealed 
conditions, the MIC of the CS-BA encapsulated essential oils was recorded at 300 mg/l 
while the nonencapsulated Thyme oil MIC 400 mg/l. Under non-sealed condition, the 
MIC of encapsulated thyme oils and non-encapsulated thyme oils were 500 mg/L and 
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1000 mg/l, respectively. Interestingly, in vivo test revealed significant anti-fungal 
properties of CS-BA encapsulated EOs at concentrations above 700 mg/l (Khalili, 2015).  
Chitosan-Alginate nanocapsules were formulated to encapsulate turmeric and 
lemongrass oil. Results showed that 0.3 mg/mL alginate and 0.6 mg/mL chitosan 
produced minimum sized particles (<300 nm) with great stability. It was also reported, 
the nanocapsules were hemocompatible, suggesting potential for biomedical and 
pharmaceutical applications. Antiproliferative activity was also shown using the 3-(4,5-
dimethy;thiazol-2-yl)-2,5,diphenyltetrzolium bromide assay. The nanocapsules were 
significantly more antiproliferative than the raw oils.  
1.5.2 Essential Oils in Microemulsions 
Formulation of microemulsions has been an avenue in applying EOs to foods. 
The Merriam Webster dictionary defines microemulsions as, “an emulsion in which the 
dispersed phase in the form of very small droplets usually produced and maintained 
with the aid of surfactants and having diameters of 50 to 500 angstroms. Sottmann and 
Stubenruach (2009) defines microemulsions as macroscopically isotropic mixtures of at 
least a hydrophilic, a hydrophobic and an amphiphilic component. Microemulsions could 
be vital in stabilizing EOs in food systems in liquid and solid phases.  
Zhang et al. (2014) formulated microemulsions for potential washing solutions 
for organic fresh produce production. The oils from clove bud, cinnamon bark, and 
thyme were mixed with sucrose octanoate ester (SOE) and soy lecithin at various mass 
ratios before dilution with water to 40% (w/w.) The EOs were then mixed with the 
surfactant solution by hand shaking. The formation of microemulsions was favored at 
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lecithin: SOE mass ratios at 4% clove bud oil 2:8 and 3:7, 4% cinnamon bark oil and 3% 
thyme oil at 2:8 and 1:9, respectively. Microemulsions comprised of polysorbate 80 
(Tween 80 TM 80) as a surfactant, water, and propylene glycol as the polar phase have 
also been prepared. The oil phase contained EOs from cinnamon bark, eugenol, or 
thymol and Soybean oil at mass ratios of 1:0, 2:1, or 4:1. Results showed that SBO added 
to EOs expands the regimes of microemulsions and reduced the droplet dimensions that 
were stable over 90 days (Qiumin and Zhong, 2016).  
In a study on the fatty liver and dyslipidemia in rats, clove essential oil (CO) and 
eugenol were formulated in water-based microemulsions. Results showed that CO 
microemulsions (COM) and eugenol microemulsions had particles sizes 8.0 nm and 8.9 
nm, respectively. Excess dilution and incubation of these microemulsions in 1.2 N HCl, to 
mimic stomach juice, for 5 hours, lead to an establishment of a sub population with 
larger particle sizes of diameters less 100.0 nm. Rats who were administered daily doses 
of COM and EM, produced improvement in all biological evaluations. The controlled 
group exhibited dyslipidemia, high plasma tumor necrosis factor-α, and liver 
dysfunction. There was no correlation in the biochemical parameters when the 
experimental groups were given the different formulations (Al-Okbi, 2014).   
1.5.3 Electrospraying Essential Oils 
Electrospraying is a method of liquid atomization by means of electrical forces. In 
this methodology, a liquid flows out of a capillary nozzle, which is maintained at high 
electrical potential, and forced by an electrical field to be dispersed into fine droplets. It 
is currently being researched for food and biomedical applications. The size of 
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electrospray droplets could range from hundreds of micrometers to several tens of 
nanometers. Droplet generation and size could be controlled via the flow rate of the 
liquid and the voltage being applied to the capillary nozzle (Jawrek & Sobczykl, 2008). 
No heat is used during the electrospraying process. More recently, this technique is 
being used to encapsulate health promoting compounds including EOs.  
Ghayempour and Mortazavi (2014) created antibacterial micro-nanocapsules by 
electrospraying oils from peppermint. In this study coaxial jet electrospray technique 
was developed to prepare the capsules. Encapsulation was achieved by preparing an 
emulsion of peppermint oil with polyoxyethylene sorbitan monolaurate emulsifier as 
the core material with 2% (w/v) sodium alginate as the wall material. SEM images 
showed that small spherical macro-nanocapsules were created. In various samples, 72% 
to 96.4% of the oil was successfully encapsulated and non-degraded. Using the shake 
flask method, the encapsulated macro-nano capsules reduced bacterial growth by 
100%. Sunflower oil based material was electrosprayed on to complex surfaces as 
coatings. Selected model surfaces were nickel membranes with large rectangular pores 
(13 µm width), polyether sulfone (PES) membranes with small interconnected pores (0.2 
µm) and dense cellulose membranes. The EO coating material penetrated the pores of 
PES and nickel membranes, filling them up and thereby significantly decreasing water 
vapor permeation flux. However, the materials accumulate on the cellulose membrane 





    
1.5.4 Electrospinning of Essential Oils 
Electrospinning is very similar to electrospraying in that an electrical current is applied 
to capillary nozzle. A direct electrical current (10-30kV) is applied to the polymer 
solution creating a charged and continuous jet. The electrified jet is stretched due to the 
electrostatic repulsions between the surface charges and evaporation of the solvent. 
Fibrous mats are collected on a collector plate. Electrospraying creates random spherical 
macro or nano-capsules while electrospinning creates well-organized fibrous mats. 
Indeed, electrospinning is a simple and rapid technique. Thus fabricated fibers display 
small diameters (10-1000 nm) and high surface-area-to-volume ratio.  
In a two-part study, antimicrobial nanofibers were fabricated by solubilizing 
eugenol (0.75-1.5 wt%) in surfactant micelles (Surfynol 465; 5-10% wt%) to form 
eugenol microemulsions (Kriegel, 2009). The microemulsions were then mixed with 
nonionic synthetic polymer poly (vinly alcohol) (PVA) to induce fiber formation. The 
mean diameter of the obtained fibers ranged from 57 - 126 nm. The surface 
conductivity and viscosity of the polymer solutions increased, while surface tension 
decreased. The mean diameter of the nanofibers decreased with increasing surfactant 
concentration and decreasing eugenol concentration. Subsequent, transmission 
electron microscopy showed that microemulsion droplets were homogenously 
dispersed throughout the nanofibers (Kriegel, 2009). Later, the antimicrobial activity and 
release characteristics of the electrospun eugenol nanofibers were tested. A burst 
release of the dispersed eugenol was noticed and the release rate was dependent on 
the eugenol and surfactant concentration. The antimicrobial activity of nanofibers was 
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evaluated against Salmonella Typhimurium (2476 and 2576) and Listeria monocytogenes 
(Scott A and 101). The presence of nanofibers in bacterial suspensions suppressed the 
test pathogens and in some cases decreased initial cell numbers (Kriegel, 2010).  
Rieger and Schiffman (2014) electrospun essential oil component, 
cinnamaldehyde into chitosan (CS) /poly(ethylene oxide) (PEO). CA (0.5 and 5%.0) was 
incorporated into CS-PEO into mats with diameters of approximately 50 nm. Release 
studies showed 5.0 CA fiber mats released higher amounts of CA-liquid (545% more) 
and CA-vapor (279% more) than the 0.5% fiber mats. The quick release of CA enabled 
high inhibition rates of Escherichia coli and Pseudomonas aeruginosa.  Reiger et al. 
(2016) later successfully electrospun CA and hydrocinnamic alcohol (H-CIN) in CS-PEO. 
Viscosity stress sweeps determined how the oils affected solution viscosity and chain 
entanglement concentration. The maximum polymer: oil mass ratio electrospun was 1:3 
and 1:6 for CS/PEO; CA and H-CIN, respectively; a higher chitosan degree of acetylation 
increased the incorporation of H-CIN.  
 Vanillin/ cyclodextrin inclusion complex nanofibers (vanillin/CD-IC NFs) were 
fabricated from the modified CD types (HPβCD, HPγCD and MβCD) in three different 
solvent systems (water, DMFand DMAc). The polymer-free vanillin/CD-IC NFs allowed a 
much higher loading of vanillin (~12% w/w) compared to polymeric nanofibers 
(~5%W/W). Maximum preservation of vanillin was observed for vanillin/MβCD-IC NFs, 
approximately ~85% w/w, while vanillin/HPβCD-IC NS and vanillin/HPγCD-IN NFs 
preserved ~75% vanillin (Celebioglu, 2016).  
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1.6 Conclusion 
Natural preservatives are in high demand for food. Today’s consumers are more 
conscious about what they consume and prefer things that come from the natural 
sources. Food spoilage and foodborne illness is still a global issue. Pathogenic 
microorganisms cause thousands of hospitalizations and deaths annually, food loss, and 
huge economic losses. Essential oils and EO components possess antimicrobial, 
antioxidant, and anti-inflammatory properties and thus they stand out as viable option 
for addressing the pathogenic issues. However, incorporation of EOs is a challenge as 
they are unstable, volatile, pungent and not water soluble. High amounts of EOs in foods 
could change the sensory attributes. Several methodologies such as encapsulation, 
microemulsions, eletrospraying, and electrospinning are being pursued to apply EOs to 
food. Though there has been tremendous success there are still some critical issues to 
be addressed and the future is set to formulate more stable and hydrophilic delivery 









    
CHAPTER 2. INTORDCUTION & METHODS 
2.1 Introduction 
Carrageenans are hydrocolloids consisting mainly of D-galactose and anhydro-
galatose units. They are used as gelling, thickening and stabilizing agents in food 
products. They are also used in medicine, pharmaceutical formulations, and cosmetics 
(Necas, 2013). They are extracted from the seaweed for example, from the coast of 
North America and Europe. They occur within the cell wall of red seaweeds and are 
usually extracted from species of Chondrus, Eucheuma, Polyides, Irideae, and Hypnea. 
Since 1962, carrageenans have been suggested to be suitable for use in food by the 
Food Additives and Contaminants Committee (Fd. Cosmet. Toxical, 1971). The FAO/ 
WHO first allocated an acceptable daily intake (ADI) of 0 – 50 mg/kg. Data from the 
expert Committee showed that carrageenans are not absorbed when ingested by 
animals nor did they cause an increase in mortality (Fd. Cosmet. Toxical, 1971). Thus, 
carrageenan is classified as safe and used for commercial applications. 
There are carbohydrate residues (e.g., xylose, glucose) and substituents (e.g., 
methyl ethers and pyruvate groups) present in carrageenan. Carrageenans are classified 
into to various types such as λ, κ, ι, ε, µ and as of today, there are 15 known varieties
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Higher levels of ester sulfate mean lower solubility temperature and lower gel strength 
(Necas, 2013). 
The most common types of carrageenans used in the food industry are kappa-, 
lambda-, and iota-carrageenan. They dissolve in water to form highly viscous solutions. 
Potassium, calcium, and sodium ions together produce high gel strengths. Gels made 
with kappa(κ)-carrageenan are the strongest of all carrageenan gels but they tend to 
synerese. Iota(ι)- carrageenan yields gelation best with calcium ions. The resulting gel is 
soft, resilient and has a good freeze-thaw stability. It does not synerese, presumably 
fewer junction zones are created compared to κ-carrageenan (Damodaran, 2008). The λ- 
carrageenan is also water-soluble but does not gel. 
It has been shown that carrageenans can be encapsulated with health promoting 
molecules. Polysaccharides like carrageenan cannot grow as large crystals, but can be 
stretched into well-oriented fibers. When carrageenans are in fiber form they take on a 
helical structure. Interestingly, carrageenan fibers held at a relative humidity (RH) of 66-
75% creates a network stabilized by a series of ordered water molecules and amorphous 
water pockets. In these water pockets are where health promoting substances can be 
deposited. These studies have also shown that carrageenan fibers can be paired with 
balancing cations like sodium, potassium, and calcium (Janaswamy and Youngren, 
2012). When molecules enter the water pockets of the carrageenan lattice it changes 
the normal packaging arrangement of the carrageenan. X-Ray Fiber Diffraction has been 
used to examine the atomic structural variations among the various forms of 
carrageenans, especially in the fiber forms. Carrageenan- cation combinations that have 
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high gel strength are likely to be capable of being grown into fiber form (Janawamy and 
Youngren, 2012). Weak gels tend to break before being stretched into fibers.  
In this study, we hypothesize that fibers can be fabricated using sodium-ι-
carrageenan solutions and encapsulate with EO components, eugenol and carvacrol. 
The EO components will be loaded into the water pockets of the fibers and the fibers 
will adopt the antibacterial functionality of eugenol and carvacrol. We suggest the 
antimicrobial compounds can quickly release from fibers and inhibit the growth of 
pathogenic bacteria. The objectives of this study are to demonstrate that well-oriented 
carrageenan fibers encapsulated with essential oils can inhibit bacterial growth and 
determine the antibacterial activity against Gram-positive and Gram-negative bacterial 
strains. 
2.2 Materials and Methods 
2.2.1 Chemicals 
All solutions were prepared with deionized water. Research grade ι-carrageenan 
sample (RE-PR-4018) was provided by FMC Corporation, USA. Sodium Chloride (NaCl) 
(X190-1Kg, Lot #; 1502C144), and eugenol (A14332, Lot #: 10172314) were purchased 
from VWR International (Batavia, IL) and Alfa Aesar, respectively. Carvacrol (Lot #: 
MKBP5684V) was purchased from Sigma-Aldrich (Milwaukee, WI). Agar, Bacteriological 
(Lot: 107530A) and Brain Heart Infusion (BHI) Broth (Lot #: 106517A) were purchased 
from Neogen Corporation (Lansing, Michigan). Bacto ™ Tryptic Soy Broth (TSB) (Lot #: 
5215822) was purchased from Fischer Scientific (Hanover Park, IL). Tween 80, ethanol, 
and acetone were used to prepare encapsulation solutions. 
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Bacterial Test Cultures 
To test the antibacterial activity of the fibers, Salmonella enterica serovar 
Heidelberg 513, Salmonella Enteritidis ENT 1344, Escherichia coli O157: H7 ATCC 43295, 
Staphylococcus aureus ATCC 25923, Listeria monocytogenes F4244, and Listeria innocua 
F4248 were used. The cultures were obtained from the Bhunia Lab culture collection, 
Department of Food Science, Purdue University.  









2.2.2 Preparation of Sodium Iota-Carrageenan (IC) Fibers 
The experimental approach to engineer IC fibers and encapsulate EO 
components in the organized network was derived from Polowsky and Janaswamy, 
(2015). This, in part, requires well-organized fiber formation, orientation and 
crystallinity. Briefly, 100 mg of IC and 36 mg of NaCl were dissolved in 10 mL of 
deionized water. The homogeneous solution was heated at 90 °C for 45 minutes with 
intermediate vortexing then cooled to ambient temperature to obtain a viscous gel. In 
# Bacterial Strain 
1 Salmonella enterica serovar Heidelberg 513 
2 Salmonella Enteritidis ENT 1344 
3 Escherichia coli O157: H7 ATCC 43295 
4 Staphylococcus aureus ATCC 25923 
5 Listeria monocytogenes F4244 
6 Listeria innocua F4248 
26 
 
    
actual fiber preparation, a 20 µl droplet of the IC gel was placed in between two glass 
rods in a fiber puller at 66% relative humidity (RH). Once the droplet dried partially 
(after around 3 – 4 hours), it was stretched to approximately 2 – 3 mm in length at 
regular intervals, and was allowed to dry further for 12 hours in the fiber puller. Then 
the fibers were cut loose from the glass rods and stored in a desiccator at 66% RH for 
further experimentation.  
2.2.4 Preparation of Antibacterial Fibers 
Several encapsulation solutions were used in the study to determine the most 
effective against the selected test organisms. Table 2 displays the various solutions and 
concentrations. All solutions were mixed until a homogenous mixture was obtained. The 
solutions were stored at ambient temperatures. Stretched fibers were immersed in the 
selected solution for 7 days at an ambient temperature. The complex fibers were then 













    








2.2.5 Eugenol and carvacrol release from the complexes and encapsulated amount 
Concentration testing was performed using a Beckman Coulter DU 730 UV/Vis 
spectrophotometer with disposable UV cuvettes. Initially, wavelength scan was 
performed in the range 200 to 600 nm for determining the optimum wavelength of 
absorbance (276 nm) for eugenol and carvacrol (270 nm). Subsequently, calibration 
curve was generated by dissolving known amounts of eugenol and carvacrol in isopropyl 
alcohol. Distilled deionized water was used as solvent for estimating the eugenol or 
carvacrol content in the complex. The fibers weighing 1.0 mg were placed at the bottom 
of the cuvette containing 600 µL of distilled deionized water. The spectrometer was 
zeroed before the measurements with cuvette containing only water. The absorbance of 
the sample was taken every 2 min for 40 mins. Eugenol and carvacrol amounts in the 
complexes were estimated using the calibration curve with the known absorbance. 
Results are presented with means of duplicate experiments.  
 
# Solution and concentration combination 
1 3% water, 47% Eugenol, 50% Ethanol 
2 3% water, 47% Carvacrol, 50% Ethanol 
3 25% Carvacrol, 25% Ethanol, 50% Tween 80 
4 50% Carvacrol, 50% Tween 80 
5 30% Carvacrol, 70% Tween 80 
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2.2.6 Antibacterial Activity Assay 
Disc diffusion assay was the first test chosen to examine the antibacterial activity 
of the fibers. Listeria innocua F4248 and Brain Heart Infusion Broth/Agar were chosen as 
the initial test microorganism and media, respectively. L. innocua was grown for 
approximately 18 h. Soft BHI agar (0.75% agar, Bacteriological) was microwaved until 
melting and allowed to cool slightly. L. innocua was inoculated at a concentration 1 x 106 
cfu/ml into 5 ml of soft agar. The inoculated soft agar was then poured onto the surface 
of a BHI agar petri dish and allowed to solidify. The control experimental groups were 
placed in the center of soft agar plates. The plates were incubated at 37oC for 24 h. After 
several trials, the zone of inhibition assay was shown to not be a viable method to 
display the antibacterial activity of carrageen-based fibers encapsulated with eugenol or 
carvacrol. Carrageenan fibers form a gel-like mass agar and possibly did not release the 
antibacterial compound onto the inoculated soft agar plate. Herein, a different method 
was assessed.    
The Beckman Coulter DU 730 UV/Vis spectrophotometer was used to conduct 
further antibacterial test. Listeria innocua F4248 and Salmonella Heidelberg 513 were 
chosen as the model test microorganisms and TSB with 0.5%yeast extract (TSBYE) was 
the media used in all further studies. The test microorganisms were grown for 
approximately 18 h then inoculated at a concentration of 1 x 106 cfu/ml. The controls 
and experimental groups were added to the appropriate 4 ml glass test tubes of 
inoculated TSBYE after 2 h of incubation for 37oC. The absorbance of all samples was 
taken every 2 hours for 12 hours at a wavelength of 600 nm. Some experiments 
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required longer analysis up to 24 hours. The UV/Vis Spectrophotometer was also used 
to rapidly screen encapsulation solutions, effect of tween 80 on EO-bacterial 
interactions, and to monitor the effect of carrageenan-based antibacterial fibers grown 
in 10% and 50% TSB. Minimum antibacterial activity was shown using the UV/Vis 
Spectrophotometer. Results are presented with means of duplicate experiments. Cell 
number calculations were derived to determine the antibacterial activity of the fibers. 
 The antibacterial activity of the carrageenan-based antibacterial fibers was also 
evaluated by treating test microorganism with the fibers and monitoring growth by 
calculating cell numbers over a 12 or 16 hour period. Initially, the test microorganisms 
were grown for approximately 18 hours then inoculated at a concentration of 1 x 106 
cfu/ml. Results in later experiments showed an initial inoculating concentration of 1 x 
104 cfu/ml is sufficient for antibacterial test. Controls and experimental groups were 
added to appropriate tubes containing 4 ml glass test tubes of TSB after 2 hours. 
Bacterial growth was monitored by enumerating cell numbers after 0, 4, 6, 8, 10, and 12 
h of incubation at 37oC. Enumeration was carried out by preparing 10-fold serial 
dilutions in phosphate buffer saline (PBS) for plating on tryptic soy agar with yeast 
extract (TSAYE). Plates were incubated for 24 h at 37oC. Results are means of duplicate 
experiments with four replicates. 
2.2.7 Scanning Electron Microscopy 
S. Enteritidis 1344 and L. monocytogenes F4244 cells were treated with 
antibacterial fibers for 8 h. The treated cells were then centrifuged for 4 min at 8000 
rpm. The 0.3% TSB was decanted to leave a visible pellet of treated cells. The cells were 
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fixed in 2.5% glutaraldehyde fixative solution. The cells were then treated with 1% 
osmium tetroxide for one hour followed by three washes of deionized water. Next, the 
cells were washed with 50% ethanol, washed twice with 70% ethanol, washed with 85% 
ethanol, three times with 95% ethanol, and three times with 100% ethanol. Lastly, cells 
were dried using hexamethyldisilazane. The cells were observed under a Nova NanoSEM 
™ 200 series microscope using an accelerating voltage of 50 kV. Images were captured 












    
CHAPTER 3. RESULTS & DISCUSSION 
3.1 Release Profile 
In the IC: eugenol fiber release was conducted in deionized water and there was 
an initial burst of eugenol release during the first 10 mins (Figure 1). The fibers 
completely released the encapsulated eugenol around 40 mins. IC: carvacrol fibers 
release studies were conducted in PBS to determine if the antibacterial component is 
released during the lag phase of bacteria growth. Results indicate the fibers also dissolve 
in PBS, and gradually release carvacrol in approximately, 40 minutes. It was concluded 
that the antibacterial molecules could be released in broth-based assays.   
 




















E u g e n o l
C a r v a c r o l
 
Figure 1. Release Profiles of eugenol and carvacrol encapsulated Iota-carrageenan fibers 
32 
 
    
3.2 Disc Diffusion Assay 
 In the disc diffusion assay analysis, antibacterial fibers did not create a 
measureable zone when BHI soft agar was inoculated with L. innocua 1x107 cfu/ml, 
1x106 cfu/ml, or 1x105 cfu/ml (Figure 2). Fibers seem to absorb water from the soft agar, 
gel and do not release the eugenol. In order for the maximum antibacterial activity to be 
demonstrated, the encapsulated eugenol must be released completely. However, when 
100 mg of complexed fibers were tested against 1x106 cfu/ml of L. innocua, an inhibition 

















Figure 2. Zone of Inhibition Assay, A. T (iota-carrageenan fibers encapsulated with 47% eugenol: 50% ethanol) 
and U (iota-carrageenan fibers) tested against 1x107 cfu/ml L. innocua. B. T and U tested against 1x106 cfu/ml C. 
T and U tested against 1x105 cfu/ml D. 5 µl of eugenol tested against 1x107 cfu/ml. 
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3.3 Antibacterial Activity Assay 
The antibacterial efficacy was determined using a UV/Vis Spectrophotometer. 
The IC: eugenol fibers were tested against L. innocua F4248 and S. Heidelberg. During 
the initial experiments, there was no noticeable reduction in bacteria treated with IC: 
Eugenol fibers (Figure 3). L. innocua treated with non-encapsulated IC fibers also 
trended with the control for 12 h. As expected, pure Eugenol completely inhibited the 
growth of L. innocua after being added to the test tube.  Results were similar when the 
complexed fibers were tested against S. Heidelberg. The S. Heidelberg sample treated 
with IC: Eugenol fibers trended with the control not having an effect on the growth of 
bacteria. Cell populations increased from 1x106 cfu/ml to 1x108 cfu/ml. Eugenol was also 
lethal to S. Heidelberg; no growth was detected in its tube.  
 
 
Figure 2. Continued, E. 100 mg of iota-carrageenan fibers encapsulated with 47% 



















Carvacrol and Eugenol were mixed with ethanol to determine their efficacy 
against S. Heidelberg.  Ethanol did not have an effect on growth of the bacteria (Figure 
4). After two hours of incubation time the optical densities (OD) of the negative control 
and ethanol sample were 0.423 and 0.391, respectively. After 12 hours of incubation 
time their optical densities were 1.099 and 1.149. No growth was detected in S. 
Heidelberg samples treated with eugenol and carvarol. After 12 hours of incubation 
time, their OD was 0.055 and 0.075. The 47% carvacrol: 50% ethanol solution was more 
effective against S. Heidelberg than the 47% eugenol: 50% ethanol solution. Optical 
 
Figure 3. Effect of IC: Eugenol fibers on the growth of bacteria, 1 µl eugenol, Non-
encapsulated Fibers- 1 mg iota-carrageenan fibers, IC- 1 mg iota-carrageenan fibers 





    
densities of samples treated with EE and CE were 0.134 and 0.005 after 2 h, 
respectively. After 12 h, the OD of samples treated with EE and CE were 0.925 and 







IC: carvacrol fibers (ICC) were tested against S. Heidelberg grown in 1.5 % TSB 
(50% of normal recipe) and 0.3% TSB media (10% of normal recipe). Results showed ICC 
were not effective against S. Heidelberg in 1.5 TSB for 12 h (Figure 5). However, there 
was a slight decrease in cell populations treated with ICC, but not significant reduction 
after 6 hours of incubation. Non- Encapsulated did not have an effect on S. Heidelberg 
cell populations but the Carvacol: Ethanol (CE) solution completely inhibited growth as 
expected. Results were different when ICC fibers were tested against S. Heidelberg in 
0.3% TSB. ICC fibers reduced cell populations after 6 h of, but cell numbers increased 8 h 
of incubation time. Interestingly, after 12 h the OD of the ICC treated sample was 
significantly lower than the negative control.  
Figure 4. Comparison of eugenol and carvacrol in an antibacterial assay, 2 µl  Ethanol, 2 µl 
Eugenol, 2 µl Carvacrol, EugenolP: Ethanol- 2 µl 47% eugenol: 50% ethanol, Carvacrol: Ethanol- 2 
µl 47% carvacrol: 50% ethanol 
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The effect of fibers encapsulated with carvacrol: Tween 80 at various concentrations 
was compared to fibers encapsulated with 49% carvacrol: 50% ethanol (Figure 6). All 
fiber samples were effective at reducing cell populations S. Heidelberg in 0.3% TSB. 
Fibers encapsulated with 50% carvacrol: 50% Tween 80 was the most effective against S. 
Hiedelberg and was comparable to positive control, Carvacrol: Ethanol After 16 h, the 
OD of the samples treated with CE and C 50%: T80 50%-F were 0.1508 and 0.2298 
respectively. However, fibers encapsulated with CE were the least effective. After 16 h 
the OD of the samples was 0.3752.  
Figure 5. Effect of IC: Carvacrol fibers on the growth of bacteria in reduced nutrient 
broth, Carvacrol: Ethanol- 2 µl 47% carvacrol: 50% ethanol, Non-encapsulated Fibers- 
5 mg iota-carrageenan fibers, IC: Carvacrol- 5 mg iota-carrageenan fibers 












IC: 50% Carvacrol-50% Tween 80 (ICCT) fibers were tested against, E. coli O157: 
H7 ATCC 43295, S. Enteritidis ENT 1344, S. Heidelberg 513, S. aureus, L. innocua F4248, 
and L. mono F4244 (Figure 7 and 8). Results showed ICCT fibers were effective against 
most bacterial strains. When S. Enteritidis was treated with ICCT fibers, cell populations 
were comparable to the control, but later slightly reduced after 8h, 10 h, and 12 h, of 
incubation.  ICCT fibers extended the lag phase of S. Heidelberg and resulted in a 1-log 
reduction. There was a 1-log difference between the control and ICCT fiber treated 
sample for 12 h. Cell populations of E. coli O157: H7 treated with ICCT fibers were 
decreased for 10 h and increased after 12 h of incubation time.  
IC: 50% Carvacrol-50% Tween 80 fibers were not effective against S. aureus. 
When S. aureus was treated with ICCT fibers, cell populations were comparable to the 
control for 12 h. The ICCT fibers were most effective against L. innocua F4248, and L. 
mono F4244. In the L. innocua test, ICCT fibers reduced cell populations by 4-logs 
Figure 6. Comparison of various IC fibers in an antibacterial assay, Carvacrol: Ethanol- 1 µl 47% carvacrol 
50% ethanol, IC: Carvacrol- 5 mg iota-carrageenan fibers encapsulated with 47% carvacrol: 50% ethanol, 
IC: 33% Carvacrol- 33% Ethanol- 33% Tween 80- 5 mg iota-carrageenan fibers encapsulated with 33% 
carvacrol: 33% ethanol: 33% Tween 80, IC: 50% Carvacrol-50% Tween 80- 5 mg iota-carrageenan fibers 
encapsulated with 50% carvacrol: 50% Tween 80, IC: 30% Carvacrol- 70% Tween 80-5 mg iota-carrageenan 




    
compared to the control after 12 h. Similarly, in the L. monocytogenes test, ICCT fibers 
reduced cell populations by 3-logs after 12 h of incubation time. Interestingly, the L. 
monocytogenes treated with ICCT fibers increased to 1 x 105 cfu/ml after 4 h of 
incubation, but later decreased back to 1 x 104 cfu/ml for the remaining time intervals of 










































Figure 7. Effect of antibacterial fibers on gram-negative bacteria, IC: 50% Carvacrol-50% Tween 





























Figure 8. Effect of antibacterial fibers on gram-positive bacteria, IC: 50% Carvacrol-50% 






    
3.4 Scanning Electron Microscopy (SEM) 
 SEM was carried out using a Nova NanoSEM ™ 200 series microscope. Images of 
IC fibers, and IC fibers encapsulated with 50% Carvacrol: 50 % Tween 80 were captured 
(Figure 9). IC fibers appeared light and were composed of flaky crystals on the surface. 
The average diameters of non-encapsulated fibers were 188.35 µm ± 59.85. However, IC 
fibers encapsulated with 50% Carvacrol: 50 % Tween 80 had smooth surfaces and 
average diameter increased to 204.70 µm ± 58. 05.  
 SEM images were also captured for the test microorganisms Salmonella 
Heidelberg and L. monocytogenes, grown in the presence of IC 50%C: 50%T80 fibers. 
The images revealed the S. Heidelberg and L. monocytogenes growth controls had 
general characteristics of the respective bacteria and appeared healthy. S. Heidelberg 
treated with IC 50%C: 50%T80 fibers were not affected by the antibacterial compound. 
The Salmonella aggregated into large clusters. L. monocytogenes treated with IC 50%C: 
50%T80 fibers were damaged. While some cells appeared healthy and unaffected, 






































Figure 9. Scanning Electron Microscopy images of fibers, Salmonella Enteritidis and Listeria 
monocytogenes treated with antibacterial fibers A. iota-carrageenan fibers, B. iota-carrageenan fibers 
encapsulated with 50% carvacrol: 50% Tween 80, C & D. S. Enteritidis growth control captured at a 
magnification of 15, 000 (low magnification) and 50, 000 (high magnification) respectively, E & F. S. 






































Figure 9 Continued. G & H. L. monocytogenes growth control captured at a low and high 
magnification, I & J.  L. monocytogenes captured at a low and high magnification 
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3.5 Discussion 
 Herein, it has been demonstrated that iota-carrageenan fibers could be 
fabricated and encapsulated with single components of essential oils. The fibers were 
tested against several pathogenic bacterial species and it was discovered that the 
complex fibers could indeed reduce the proliferation of tested microorganisms. Release 
studies were conducted on two types of antibacterial fibers, IC 49% eugenol: 50% 
ethanol and IC 50% carvacrol: 50% Tween 80. The antibacterial fibers are quickly 
saturated, releasing the EO components in approximately 40 mins. Fibers containing 
eugenol and ethanol released the antibacterial compound with a quick burst while the 
carvacrol was released from the fibers gradually over time. The differences in release 
rate could be attributed to the encapsulated ethanol and Tween 80. Both ethanol and 
Tween 80 are miscible in water, but Tween 80 is a larger molecule than ethanol.  Both 
types of fibers encapsulated approximately the same amount of the EO components.  
Initially, eugenol and ethanol were used as the antibacterial encapsulation solution for 
fibers, but the antibacterial effect was not significant. It was later determined that 
carvacrol has a lower minimum inhibitory concentration than eugenol (Burt, 2004). Our 
study clearly suggests that in an antibacterial assay, carvacrol mixed with ethanol was a 
more effective encapsulation solution than eugenol: ethanol. During our study, it was 
suggested; nutrients in broth could interfere with the antibacterial effect of fibers 
encapsulated with essential oil components. Results in Fig 6. suggest, antibacterial fibers 
can reduce the growth of bacteria in 1.5 TSB % and 0.3 TSB % (0.50% and 10% original 
TSB composition, respectively). 
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Initially, fibers were dried of the encapsulation solution overnight and treated to 
the test microorganisms in the beginning of the assay the following day (Fig 3 & 4). Due 
to the volatility of essential oils, some of the antibacterial effect was lost. For the 
purpose of optimization, fibers were dried for two hours and treated to the test 
microorganisms two hours after inoculation of bacteria (Fig 5-8).  We also showed 
Tween 80 serves as a viable surfactant in Iota-carrageenan fibers. Herein, IC 50% 
carvacrol: 50% Tween 80 fibers were used to be tested against pathogenic bacteria (Fig 
6).  
  Our antibacterial compounds reduced the growth of L. monocytogenes and L. 
innocua, but were not effective when tested against Salmonella and E. coli. Similar 
results were reported by Krigel et al  (2009, 2010) when they electrospun fibers 
containing eugenol, surfactant solution Surfynol 465®, and poly (vinyl alcohol). These 
fibers were tested against two stains of L. monocytogenes and Salmonella Typhimurium. 
Cell populations in both bacteria species were reduced for 12 hours. However, cell 
populations increased Salmonella Typhimurium 2486 increased comparable to the 
growth control after 30 hours. Interestingly, cell populations were decreased 
tremendously after 30 hours in assay with Salmonella Typhimurium 2576. Some 
researchers have reported Gram-positives to be more susceptible to the action of EOs 
and EO components. The claim cannot be made in the case of our iota-carrageenan-EO 
complexes as Salmonella and E. coli (Gram-negative) were more susceptible than 
Staphylococcus aureus (Gram-positive). Gram-negative cells possess an outer membrane 
surrounding their cell wall, which could restrict diffusion of hydrophilic compounds 
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through its lipopolysaccharide layer. However, EOs are capable of disintegrating through 
the outer membrane layer and increasing permeability in the cytoplasmic membrane. 
Perhaps the microorganism’s response to the mode of action of antibacterial 
compounds is genetic or they could be resistant. Organisms may acquire genes encoding 
enzymes, such as β-lactamases, that destroy the antibacterial agent before it takes 
effect. Bacteria may acquire efflux pumps that extrude the antibacterial agent from the 
cell before it can reach its target site.  Bacteria can also acquire several genes for a 
metabolic pathway that alters the cell wall that no longer contains the binding sites of 
the antimicrobial agents (Tenover, 2006). However, there is no scientific evidence of EO 
resistance due to genetics. This may be of scientific interest in the future.   
 Tween 80 was a more effective surfactant than ethanol in terms of the 
antibacterial activity of the fibers. It should be investigated how other surfactants could 
affect the loading and release nature of essential oils from the polysaccharide fibers. 
Various balancing ions could also be paired with iota-carrageenan, namely calcium, 
magnesium and potassium, to name a few and have an effect on the loading amount 
and mechanism. Combinations of EO components have reportedly had synergistic 
effects when tested against bacteria. EO components have also had synergetic effects 
with food preservatives (Burt, 2004). This should be considered in further studies with 
polysaccharide fibers. Encapsulation of essential oils into antibacterial polysaccharides 
should also be considered in further studies. 
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Appendix A Additional Results of Antibacterial Activity Assays 
Appendix A contains results from trial antibacterial assays that contributed to the 
foundation of our methodology to demonstrate the antibacterial activity of well-
organized iota-carrageenan fibers encapsulated with essential oil components. Figure 
A.1. displays results from an assay conducted to determine if 0.01% Tween 80 had an 
effect on the growth of bacteria when it is added to tryptic soy broth with yeast extract 
(TSBYE) at various times intervals or premixed in TSBYE. Results showed, when 0.01% 
Tween 80 is added to TSBYE after 0, 2, and 4 h of inoculation, it does not have an effect 
on the growth of bacteria. When 0.01% Tween is premixed with TSBYE, it slightly 
reduced the proliferation of Listeria innocua F4248 after 6 hours. Figure A.2. contains 
results from an assay conducted to determine if the most viable time treat bacteria with 
IC: eugenol fibers. Eugenol (1μl) was a positive control. Results showed that IC: eugenol 
fibers did not have an effect on the growth of Listeria innocua F4248 when treated after 
0, 2, or 4 h after inoculation. Figure A.3. displays results for an assay conducted to 
determine the efficacy of various essential oils encapsulated in iota-carrageenan fibers 
and tested against Listeria innocua F4248. IC fibers encapsulated with 47% eugenol, 
carvacrol, or trans-cinnamaldehyde did not show major differences in levels of efficacy. 
Carvacrol (1μl) inhibited the growth of L. innocua F4248 significantly. Figure A.4. dsiplays 
results from an experiment conducted to compare IC fibers containing 0.1% Tween 80, 
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encapsulated with various concentrations of carvacrol, and tested against Salmonella 
enterica serovar Heidelberg 513. Results showed fibers at effective at several 
concentrations (10-100%). IC fibers containing 0.1% Tween 80 and encapsulated with 
















Figure A.2. Listeria innocua F4248 treated with IC: Eugenol fibers at different time 
intervals 
(h) 









Figure A.3. Comparison of IC fibers encapsulated with various essential oil components on the growth 
of Listeria innocua F4248 
Figure A.4. Comparison of IC fibers encapsulated with carvacrol at various concentrations and treated 
to Salmonella Heidelberg 
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Appendix B Raw Data 
 Appendix B contains raw data from results displayed in Chapter 3 (Table B.1-12). 





















0 0 0 
2 2.301673 0.539125 
4 2.671729 0.915995 
6 2.691003 1.476985 
8 2.770025 1.764672 
10 3.438825 1.957422 
12 2.814355 2.216341 
14 3.128517 2.377445 
16 2.823992 2.506904 
18 3.030221 2.647871 
20 2.881813 2.691024 
22 2.787372 2.705409 
24 2.929998 2.826237 
26 2.829774 2.875144 
28 2.949271 2.912543 
30 2.785444 2.901036 
32 2.976255 2.938435 
34 2.89145 2.978711 
36 2.625472 3.027618 
38 3.246087 3.050633 
40 2.978182  
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Time 










 OD (600nm) 
      
0 0.098± 0.012 -0.012± 0.018 0.016± 0.011 -0.025± 0.045 
4 1.047± 0.096 1.023± 0.065 0.964± 0.060 0.149± 0.130 
6 1.060± 0.077 1.187± 0.119 0.987± 0.004 0.076± 0.108 
8 1.046± 0.074 1.187± 0.076 1.120± 0.111 0.062± 0.012 
12 1.098± 0.059 1.180± 0.217 0.927± 0.136 0.114± 0.041 
Table B. 2. Effect of IC: Eugenol Fibers on the growth Salmonella enterica serovar Heidelberg 513   
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 OD (600nm) 
      
0 0.030± 0.034 -0.076± 0.026 -0.004± 0.041 -0.040 0.029 
2 0.081± 0.054 0.071± 0.018 0.107± 0.014 0.104 0.002 
4 0.068± 0.096 0.104± 0.072 0.087± 0.103 0.046 0.007 
6 0.517± 0.508 0.503± 0.326 0.547± 0.475 0.110 0.062 
8 1.125± 0.112 1.158± 0.192 1.170± 0.099 0.146 0.041 
12 1.160± 0.072 1.119± 0.241 1.167± 0.097 0.096 0.141 
Table B. 3. Effect of IC: Eugenol Fibers on the growth Listeria innocua F4248 
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Treatment 2 h 12 h 
 OD (600 nm) 
   
Control 0.423 1.100 
Ethanol 0.391 1.150 
Eugenol 0.0977 0.0548 
47% Eugenol: 50% Ethanol 0.134 0.926 
47% Carvacrol: Ethanol 0.0045 0.0316 
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Table B. 5 Effect of IC: Carvacrol fibers on the growth of Salmonella Heidelberg in 1.5% 





























  (600nm)        
         
0 0  0  0  0  
2 0.253± 0.126 0.140± 0.089 0.333± 0.191 0.271± 0.164 
4 0.747± 0.055 0.214± 0.286 0.756± 0.039 0.627± 0.223 
6 0.753± 0.065 0.223± 0.322 0.749± 0.028 0.729± 0.038 
8 0.778± 0.070 0.240± 0.306 0.739± 0.082 0.686± 0.073 
10 0.775± 0.076 0.204± 0.294 0.755± 0.061 0.680± 0.119 
12 0.780± 0.125 0.274± 0.358 0.722  0.629± 0.011 
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Table B. 6 Effect of IC: Carvacrol fibers on the growth of Salmonella Heidelberg in 0.3% 




























  (600nm)        
         
0 0  0  0  0  
2 0.087± 0.077 0.089± 0.001 0.169± 0.071 0.163± 0.0001 
4 0.163± 0.035 0.286± 0.022 0.196± 0.067 0.163± 0.052 
6 0.230± 0.047 0.322± 0.001 0.219± 0.063 0.163± 0.004 
8 0.301± 0.042 0.306± 0.001 0.261± 0.050 0.163± 0.039 
10 0.312± 0.020 0.294± 0.028 0.354± 0.023 0.163± 0.005 
12 0.42  0.35  0.32  0.21  
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IC: 50% Carvacrol: 50% Tween 80 
 cfu/ml    
     
0 1.943E+04± 1.034E+04 1.886E+04± 1.195E+04 
4 2.985E+06± 2.350E+06 6.167E+05± 2.881E+05 
6 3.871E+07± 3.005E+07 6.385E+07± 1.043E+08 
8 1.943E+08± 6.680E+07 6.850E+07± 3.548E+07 
10 3.800E+08± 1.310E+08 8.900E+07± 3.252E+07 
12 3.929E+08± 1.186E+08 8.000E+07± 3.763E+07 
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Table B. 8. Effect of antibacterial fibers on Salmonella enterica serovar Heidelberg 513 
Time (h) Control 
 
IC: 50% Carvacrol: 50% Tween 80 
 cfu/ml    
     
0 1.500E+04± 6.904E+03 1.771E+04± 1.242E+04 
4 1.186E+06± 8.295E+05 2.475E+05± 2.473E+05 
6 3.338E+07± 2.087E+07 1.208E+06± 5.665E+05 
8 1.829E+08± 7.111E+07 8.350E+06± 2.333E+06 
10 2.457E+08± 7.300E+07 3.100E+07± 1.273E+07 
12 2.825E+08± 8.049E+07 1.900E+07± 8.544E+06 
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Table B. 9. Effect of antibacterial fibers on Escherichia coli O157: H7 ATCC 43295 
 
Time (h) Control IC: 50% Carvacrol: 50% Tween 80 
 cfu/ml    
     
0 1.414E+04± 7.734E+03 1.313E+04± 7.080E+03 
4 5.800E+04± 3.033E+04 2.500E+04± 7.071E+03 
6 2.117E+05± 1.745E+05 8.500E+04± 1.732E+04 
8 3.620E+05± 1.795E+05 1.800E+05± 9.274E+04 
10 1.349E+06± 1.306E+06 5.950E+05± 5.049E+05 
12 5.300E+06± 1.901E+06 7.450E+06± 1.909E+06 
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Time (h) Control 
 
 
IC: 50% Carvacrol: 50% Tween 80 
 cfu/ml    
     
0 1.650E+04± 6.714E+03 1.188E+04± 5.083E+03 
4 2.430E+05± 5.962E+04 1.617E+04± 1.070E+04 
6 2.115E+06± 6.063E+05 2.450E+04± 1.168E+04 
8 2.000E+0  2.850E+04± 7.550E+03 
10 7.720E+07± 2.687E+07 2.500E+04± 2.121E+04 
12 2.175E+08± 5.679E+07 1.188E+04± 5.083E+03 
Table B. 10. Effect of antibacterial fibers on Listeria innocua F4248 
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Time (h) Control IC: 50% Carvacrol: 50% Tween 80 
 cfu/ml    
     
0 2.620E+04± 1.566E+04 2.286E+04± 1.842E+04 
4 6.675E+05± 5.000E+05 2.000E+05± 1.358E+05 
6 4.606E+06± 4.130E+06 1.000E+05± 1.131E+05 
8 1.338E+07± 4.106E+06 1.300E+05± 7.550E+04 
10 2.617E+07± 1.063E+07 9.667E+04± 9.292E+04 
12 2.100E+07± 5.944E+06 1.500E+04± 7.071E+03 
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Table B. 12. Effect of antibacterial fibers on Staphylococcus aureus ATCC 25923 
  
Time (h) Control IC: 50% Carvacrol: 50% Tween 80 
 cfu/ml    
     
0 2.667E+04± 1.481E+04 1.871E+04± 1.729E+04 
4 9.100E+05± 1.919E+06 4.613E+05± 2.405E+05 
6 2.788E+05± 1.425E+05 8.250E+05± 5.315E+05 
8 2.980E+05± 2.450E+05 1.263E+06± 1.054E+06 
10 3.275E+05± 1.854E+05 9.100E+05± 5.682E+05 
12 8.017E+05± 5.552E+05 2.123E+06± 1.202E+06 
16   8.000E+05± 3.536E+05 
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Appendix C Media Composition 
Appendix C contains the composition of the different media used in this study. Vendors 
and lot numbers of chemicals are located in chapter 2.  
Table C. 1. Brain Heart Infusion Broth (1 liter) 
17.5 g (BHI) 
1000 ml deionized water 
 
Table C. 2 Brain Heart Infusion Agar (1 liter) 
17.5 g (BHI) 
8 g agar 
1000 ml deionized water 
 
Table C. 3. Tryptic Soy Broth with Yeast Extract (1liter) 
30 g (TSB) 
5 g yeast extract 
1000 ml deionized water 
Table C. 4. Tryptic Soy Agar with Yeast Extract (1liter) 
30 g (TSB) 
5 g yeast extract 
8 g agar 
1000 ml deionized water 
Table C. 5. 1.5% Tryptic Soy Broth (1 liter) 
15 g (TSB) 
1000 ml deionized water 
 
Table C. 6. 0.3% Tryptic Soy Broth 
3 g (TSB) 
1000 ml deionized water 
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Appendix D Microorganism Growth Conditions 
 Brain heart infusion (BHI) media was used to grow L. innocua F4248 for disc 
diffusion assay. One loop of L. innocua was taken from a frozen stock and inoculated 
into 4 ml of BHI. The inoculated test tube was incubated at 37oC for approximately 18 h. 
Tryptic soy broth with yeast extract (TSBYE) was used to cultivate all microorganisms in 
antibacterial activity assays in the study. Subcultures of the test microorganism were 
prepared by streaking one loop onto tryptic soy agar plates with yeast extract. The 
streaked plates were incubated at 37oC for 24 h. One single colony from the subculture 
plate was inoculated into 4 ml of TSBYE. The inoculated tube was incubated at 37oC for 
approximately.  
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